Retatrutide

About Retatrutide

  • Retatrutide is a new treatment for those who are overweight or living with obesity
  • The medication has not yet received approval or become available
  • It works by targeting three different receptors at the same time
  • Clinical trials to date suggest potential weight loss of up to 24%
  • Side effects seem to be similar to those seen with other GLP-1 medications
Retatrutide: new weight loss medication in development

Retatrutide is a new medication that is currently attracting considerable attention as a potential treatment for overweight and obesity. It belongs to a new generation of drugs that are demonstrating promising results in research. Retatrutide is not yet approved or available at present. As soon as this changes, we will keep you updated.

What is Retatrutide?

  • Retatrutide is a GLP-1/GIP/GCGR agonist that is currently under development.
  • Clinical studies suggest it may aid weight loss and help regulate blood sugar levels.
  • Its mechanism of action appears to be partly similar to established agents such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), but retatrutide targets three receptors at once.
  • The drug remains in the research phase and has not yet been approved for use in Europe.
Mechanism of action of Retatrutide
Side effects of Retatrutide
Research on Retatrutide
Status and availability of Retatrutide
What can you do now?
Sources

Affiliated doctors

You know perfectly well what's good and what isn't good for you. Nevertheless, making the right choice can be difficult. We are Doctoronline. We believe in self-management when it comes to your health.